News & Updates
Filter by Specialty:

Dupilumab-associated ocular surface disease less common in children, teens with AD
18 Jan 2025
byMike Ng
The incidence of ocular surface disease associated with dupilumab treatment for moderate-to-severe atopic dermatitis is lower in children and adolescents than that described in adults, suggests a retrospective review at a tertiary paediatric hospital in Singapore
Dupilumab-associated ocular surface disease less common in children, teens with AD
18 Jan 2025
CAR T-cell therapy may overcome poor prognosis tied to conventional tiNHL therapies
17 Jan 2025
byAudrey Abella
A real-world study presented at ASH 2024 shows that CD19 chimeric antigen receptor (CAR) T-cell therapy is highly effective and has an acceptable toxicity profile for individuals with transformed indolent non-Hodgkin lymphoma (tiNHL).